Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-blind, Placebo-controlled Phase 2B Study on Safety and Therapeutic Efficacy of DAS181 in Adult Subjects With Naturally Acquired Influenza.

NCT01740063 is registered in ClinicalTrials.gov with Ansun Biopharma, Inc. as lead sponsor.

NCT NCT01740063
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01740063 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-blind, Placebo-controlled Phase 2B Study on Safety and Therapeutic Efficacy of DAS181 in Adult Subjects With Naturally Acquired Influenza.
Lead sponsor
Ansun Biopharma, Inc.
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2012
Completion date
January 31, 2014
Enrollment
423 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

influenza